AI Article Synopsis

  • The study investigated early and late menopause prevalence among women in Rafsanjan, Iran, using data from the Rafsanjan Cohort Study and involving 2002 postmenopausal women.
  • The average age of menopause was found to be about 48.6 years, with 11.49% experiencing early menopause and 11.39% experiencing late menopause.
  • Factors such as height, smoking, diabetes, and hormonal contraceptive use were linked to variations in menopausal age, highlighting their potential impact on women's health.

Article Abstract

Our investigation aimed to evaluate the prevalence of early and late menopause and its determinants in adult women of Rafsanjan cohort study. We used data obtained from the Rafsanjan Cohort Study, as a part of the prospective epidemiological research studies in Iran. In this cross-sectional research, 2002 postmenopausal women were included in the present study. Menopause age were divided into three groups (≤ 41 years, 42-54 years, and ≥ 55 years) based on the 10th and 90th percentile. The association between age at menopause with demographic and reproductive characteristics and some clinical risk factors of women was evaluated by logistic regressions. The mean age at menopause among the study participants was 48.63 ± 5.37 years. In this study, 11.49% and 11.39% of the women experienced early and late menopause respectively. After adjusting for all potential confounders, the results showed that taller and smoker women had higher odds of early menopause (OR 1.03, 95% CI 1.00-1.06) and OR 1.85, 95% CI 1.01-3.41) respectively) and women with history of using hormonal contraceptive more than median had lower odds of early menopause (OR 0.61, 95% CI 0.41-0.91). Also older women (OR 8.65, 95% CI 5.31-14.08) and women with a history of diabetes (OR 2.42, 95% CI 1.63-3.60), hypertension (OR 2.06, 95% CI 1.42-2.97), thyroid disease (OR 1.85, 95% CI 1.07-3.20) and depression (OR 2.00, 95% CI 1.35-2.97) had higher odds of late menopause. The results showed that the year of birth, height, smoking, history of diabetes, hypertension, thyroid disease and depression and using hormonal contraceptive were significantly associated with the menopausal age. Since age at menopause can affect subsequent health in women, understanding the determinants of menopausal age is important and should be pursued.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892520PMC
http://dx.doi.org/10.1038/s41598-023-28526-yDOI Listing

Publication Analysis

Top Keywords

late menopause
16
early late
12
rafsanjan cohort
12
cohort study
12
age menopause
12
menopause
10
women
9
prevalence early
8
menopause determinants
8
higher odds
8

Similar Publications

Primary malignant melanoma of the vagina: A case report of a rare disease that is difficult to diagnose.

Medicine (Baltimore)

January 2025

Department of Obstetrics and Gynecology, Dong-A University, College of Medicine, Busan, Republic of Korea.

Rationale: Malignant melanoma is a rare cancer that accounts for approximately 1% of all cancers. Primary malignant melanoma of the female genital tract accounts for approximately 3% to 7% of all malignant melanomas, and 0.3% to 0.

View Article and Find Full Text PDF

Background: Alzheimer’s affects women 2:1 compared to men, suggesting sex‐specific factors driving risk. Menopause, a female‐specific phenomenon, induces a multi‐system response across endocrine, metabolic, and immune‐inflammatory systems. Despite known effects on these systems, the impact on the brain and AD risk remains incompletely understood, limiting preventative options.

View Article and Find Full Text PDF

Background: Reported effects of Hormone Replacement Therapy (HRT) on late‐life neurodegenerative disease are inconsistent. Variability in the timing and formulation of HRT, plus whether an individual carries an Apolipoprotein (APOE) e4 genetic risk variant for Alzheimer’s Disease (AD), likely contribute to conflicting results. Additionally, whilst many studies have focused exclusively on the effects of exogenous oestrogen, the inclusion of testosterone in HRT appears protective against AD pathology, specifically in APOE e4 carriers.

View Article and Find Full Text PDF

Potential Regulation of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript1 by Estrogen in Parkinson's Disease.

Life (Basel)

December 2024

Institute of Global Health and Human Ecology, School of Science and Engineering, American University in Cairo, AUC Avenue, New Cairo 11835, Egypt.

Parkinson's disease (PD) is the second-leading cause of death among neurodegenerative disease after Alzheimer's disease (AD), affecting around 2% of the population. It is expected that the incidence of PD will exceed 12 million by 2040. Meanwhile, there is a recognized difference in the phenotypical expression of the disease and response to treatment between men and women.

View Article and Find Full Text PDF

Dietary Factors Associated with Depressive Symptoms in Midlife Women 40-50 Years of Age Living in the United States.

Womens Health Rep (New Rochelle)

December 2024

Department of Family Health Care Nursing, School of Nursing, University of California, San Francisco, California, USA.

Article Synopsis
  • The study examines the dietary factors that may influence depression risk in healthy premenopausal women, revealing that about 30% of participants showed signs of depression.
  • High-risk women consumed more polyunsaturated fats, omega-6 fatty acids, and sucrose, while having lower intakes of beneficial nutrients like galactose, vitamin C, and omega-3s compared to their low-risk counterparts.
  • The results suggest that prioritizing healthier dietary choices, alongside exercise and sleep, could enhance mental health interventions for women approaching menopause.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!